Known allergy to any of the study agents or to compounds of similar chemical or biologic composition are excluded (including other somatostatin analogs)
Known hypersensitivity to compounds of similar chemical composition to BMX-
Known allergy to compounds of similar chemical or biologic composition to nivolumab
Patients with known allergy to eggs or to compounds with a similar chemical or biologic composition to PROSTVAC or nivolumab
Known allergy to compounds of similar chemical or biologic composition to nivolumab
Known hypersensitivity to -fluorouracil, capecitabine, bevacizumab or to any component of the investigational products or compounds of similar chemical composition
Poor tolerability or known allergy to any of the study drugs or compounds of similar chemical or biologic composition to lenalidomide, bortezomib and/or dexamethasone
Poor tolerability or known allergy to lenalidomide, bortezomib and/or dexamethasone or compounds that have similar chemical or biologic composition to these study drugs
History of hypersensitivity to LCI or to drugs of similar chemical classes.
Poor tolerability or known allergy to any of the study drugs or compounds of similar chemical or biologic composition to dexamethasone, boron or mannitol
Poor tolerability or known allergy to any of the study drugs or compounds of similar chemical or biologic composition to lenalidomide, bortezomib, panobinostat and/or dexamethasone
Known hypersensitivity to -fluorouracil or to any component of the investigational products or compounds of similar chemical composition
History of allergy or reaction attributed to compounds of chemical or biologic composition similar to those of MEDI- or AI
Known or suspected allergy to any recombinant human antibodies, or compounds of similar chemical or biologic composition to sorafenib or any of the drugs in this study
Subjects with history of hypersensitivity to compounds of similar chemical or biologic composition of XILONIX.